Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DICE Trial
NCT04772222Phase 2Completed
- Sponsor
- University of Utah
- Start
- Jun 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in hypoxic-ischemic encephalopathy (HIE), pain, sponsored by University of Utah. Started Jun 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hypoxic-ischemic encephalopathy (HIE)pain
Beyond the preview
Go deeper on NCT04772222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04772222.